Patent Application
20240359029
The present disclosure relates generally to treating vitamin D deficiency and more particularly to a phototherapy device for treating vitamin D deficiency.
Vitamin D is used by the body in association with calcium (e.g., in bone formation). Most popularly, vitamin D deficiency is associated with rickets, a disease in which the bone tissue doesn't properly mineralize, leading to soft bones and skeletal deformities. The importance of vitamin D is becoming increasingly understood, with research pointing to the importance of vitamin D in protecting against a host of health problems.
When your skin is exposed to sunlight, it manufactures vitamin D. The sun's ultraviolet B (UVB) rays interact with a protein called 7-DHC in the skin, converting it into vitamin D3, the active form of vitamin D.
The present disclosure provides a phototherapeutic footwear for treating vitamin D deficiency using a light source emitting UVB light to stimulate production of vitamin D by a patient's body and emitting red light to stimulate melatonin production by the patient's body.
While a number of features are described herein with respect to embodiments of the invention; features described with respect to a given embodiment also may be employed in connection with other embodiments. The following description and the annexed drawings set forth certain illustrative embodiments of the invention. These embodiments are indicative, however, of but a few of the various ways in which the principles of the invention may be employed. Other objects, advantages and novel features according to aspects of the invention will become apparent from the following detailed description when considered in conjunction with the drawings.
The annexed drawings, which are not necessarily to scale, show various aspects of the invention in which similar reference numerals are used to indicate the same or similar parts in the various views.
The present invention is described below in detail with reference to the drawings. In the drawings, each element with a reference number is similar to other elements with the same reference number independent of any letter designation following the reference number. In the text, a reference number with a specific letter designation following the reference number refers to the specific element with the number and letter designation and a reference number without a specific letter designation refers to all elements with the same reference number independent of any letter designation following the reference number in the drawings.
According to a general embodiment, a phototherapeutic footwear is provided for treating vitamin D deficiency using UVB light and red light. The phototherapy device includes a light source configured to emit UVB light to stimulate production of vitamin D by a patient's body and to emit red light to stimulate melatonin production by the patient's body. by co-activating the production of vitamin D and melatonin, it is possible to obtain synergistic effects due to melatonin's role in enhancing the signaling of vitamin D. The light source and a power source are mechanically supported by a main body, such that the UVB light and red light are directed onto a skin of a patient.
An exemplary phototherapeutic footwear 10 for treating vitamin D deficiency is shown in
The main body 16 includes a proximal end 24 having an opening 26, a distal end 28, and an interior 30 bounded by the main body 16. The main body 16 is configured to receive a foot 32 and/or leg of a patient. The main body 16 supports the light source 12 such that the phototherapeutic light 18 is emitted into the interior 30 of the main body 16.
As shown in
The light emitters 34 may also include blue light emitters 40 that emit germicidal blue light 42. A wavelength range of the blue light 42 includes a wavelength of 405 nm. For example, the blue light 42 may include the wavelength 405 nm and additional wavelengths.
As shown in
In one embodiment, the light source includes UVB light emitters 36 and red light emitters 38. The light emitters 34 may be positioned to emit the phototherapeutic light 18 such that the phototherapeutic light 18 is received by a light receiving end of the light guides 16. Each of the light guides 46 may receive phototherapeutic light 18 from a single type of light emitter (e.g., one or more UVB light emitters 36 or one or more red light emitters 38). Alternatively, at least a portion of the light guides 46 may receive phototherapeutic light 18 from more than one type of light emitter.
The main body 16 may be at least partially made of a woven fabric and the light guides 46 may be interwoven into the woven fabric. For example, the light guides 46 may be included as a woven strand in the woven fabric. Alternatively, the light guides 46 may be attached to an interior surface of the main body 16. As an example, the main body 16 may be made of a dual layer of woven fabric and the light guides 46 may be sandwiched between the layers of the dual layer of woven fabric.
The phototherapeutic footwear 10 may additionally include processor circuitry 44 for controlling the emission of the phototherapeutic light 18. The processor circuitry 44 may control the UVB light emitters 36 separately from the red light emitters 38. For example, the processor circuitry 44 may independently operate the UVB light emitters 36 (i.e., modulate the emission of the UVB light 20) and the red light emitters 38 (i.e., modulate the emission of the red light 22). Similarly, the processor circuitry 44 may independently operate the blue light emitters 40 from the UVB light emitters 36 and the red light emitters 38.
In one embodiment, the processor circuitry 44 separately controls a dosage of the UVB light 20 emitted by the light source 16 and a dosage of the red light 22 emitted by the light source 16. For example, the processor circuitry 44 may measure a dosage of the UVB light 20 emitted by the light source 16. The processor circuitry 44 may also measure a dosage of the red light 22 emitted by the light source 16. The processor circuitry 44 may measure a dosage of a type of light (e.g., UVB light 20 or red light 22) based on an amount of time (i.e., a time duration) over which the type of light was emitted. For example, the processor circuitry 44 may keep track of a total time duration that UVB light 20 was emitted by the UVB light emitters 36 over a 24 hour period. The processor circuitry 44 may use this time duration to calculate a dose of UVB light 20 by multiplying the time duration by a known factor.
The processor circuitry 44 may also turn off a light emitter when the dosage of the associated light exceeds a threshold. For example, when the measured dosage of the UVB light 20 is greater than or equal to a UVB dosage threshold, the processor circuitry 44 may stop the emission of the UVB light 20 (e.g., for the remainder of the day). Alternatively, or additionally, when the measured dosage of the red light 22 is greater than or equal to a red dosage threshold, the processor circuitry 44 may stop the emission of the red light 22. For example, the processor circuitry 44 may limit dosage by specifying the UVB dosage threshold as a duration of time and limit the cumulative amount of time that the UVB light emitters 36 emit the UVB light 20 to less than the UVB dosage threshold. Similarly, comments apply concerning the red light emitters 38 and red light 22.
In one embodiment, the phototherapeutic footwear includes a dosage sensor (also referred to as a dosimeter) configured to sense a dosage of at least one of UVB light or red light received by the patient. For example, the dosage sensor may sense a dosage of UVB light and/or red light received from the ambient environment. This sensed dosage may be added to the dosage of the UVB light and/or red light and used to determine when the UVB dosage threshold and/or red dosage threshold has been met.
The processor circuitry 44 may also limit emission of a type of light based on a time of day. For example, the processor circuitry 44 may determine a time of day (e.g., using an internal or external clock) and compare the time of day to a red light initiation threshold. The red light initiation threshold may identify an earliest time for beginning emission of the red light 22 by the red light emitters 38. When the time of day is after the red light initiation threshold, the processor circuitry may cause the light source 12 to emit the red light 22. The red light initiation threshold may be set using any suitable method (e.g., based on typical environmental increase in proportion of red light during the day/night cycle).
The phototherapeutic footwear 10 may also include a sensor 50 for detecting when the foot 32 is inserted into the opening 26. The sensor 50 may be used to minimize the phototherapeutic light 18 being transmitted into the external environment (i.e., outside of the main body 16) by detecting when the opening 26 is obstructed and preventing the phototherapeutic light 18 from being transmitted into the external environment through the opening 26. The processor circuitry 44 may stop the emission of the UVB light 20 when the sensor 50 detects that the foot 32 is not inserted into the opening 26. For example, the sensor 50 may detect an obstruction in the opening 26. When the sensor 50 detects an obstruction, the processor circuitry 44 may enable the light source 16 to emit the phototherapeutic light 18. Conversely, when the sensor 50 detects that the opening 26 is not obstructed (i.e., a foot 32 or some other object is not inserted into the interior 30 of the main body 16), the processor circuitry 44 may disable the light source 16, such that the phototherapeutic light 18 is not emitted (e.g., the processor circuitry 44 may not send a signal to the light source 16 to emit the phototherapeutic light 18).
The sensor 50 may be any suitable device for detecting when a foot 32 is inserted into the opening 26. For example, the sensor 50 may be a photodetector (e.g., one or more photodetectors located at the proximal end 24 of the main body 16) for detecting light. When the phototherapeutic footwear 10 is worn by a patient, the patient's leg and/or foot may block the sensor 50, such that the sensor 50 does not detect light. Conversely, when the phototherapeutic footwear 10 is not being worn, the sensor 50 may be unobstructed such that light is detected by the sensor 50.
The processor circuitry 44 may initiate emission of the phototherapeutic light 18 when the sensor 50 detects at a current time point that the foot 32 is inserted (i.e., newly inserted) into the opening 26 after the sensor 50 detected at a previous time point that the foot 32 was not inserted into the opening 26. That is, the processor circuitry 44 may initiate emission of the phototherapeutic light 18 (e.g., at least one of the UVB light 20 or the red light 22) when the user puts the phototherapeutic footwear 10 on. The processor circuitry 44 may detect when a user puts the phototherapeutic footwear 10 on by the sensor 50 transitioning from indicating that a foot 32 is not detected (i.e., a foot is not inserted into the opening 26) to indicating that a foot 32 is detected.
The phototherapeutic footwear 10 may be any suitable footwear covering a portion of a patient's foot 32. In the embodiments shown in
In another embodiment, as shown in
The main body 16 may completely or partially enclose the interior 30 of the main body 16. For example, the main body 16 may have an open toe or may include other openings. Alternatively, as shown in
The light guides 46 may take the form of a flat fiber insert and the light source 16 may be arranged in a strip that is aligned along one edge of the insert. With a series of light emitters 34 (e.g., LEDs), the phototherapeutic light 18 may be well distributed, and a rudimentary style of coupling optic may be used (e.g., a molded acrylic strip with a series of indents on one side to receive the light emitters 34 and on the other side a cavity to receive the light receiving ends of the light guides 46).
The light guide 46 may be made of any suitable material having a structure, such that light emitted by the light source 16 and received by the light guide 46 is propagated via total internal reflection. For example, the light guide 46 may comprise a series of optical fibers (e.g., made from glass or plastic). The light guides 46 may include multiple separate structures (e.g., fiber optics) or a single structure (e.g., flat fiber).
The light emitters 34 may comprise light emitting diodes (LEDs), micro-LEDs, organic LEDs (OLEDs), polymer light emitting diodes (PLED)), a mercury lamp (e.g., including a spectral filter), or any suitable source of light. For example, a clad flat fiber and LEDs may be encased in a gel. Electrical connection may be made to the LEDs at an edge of the gel. In an alternative embodiment, micro-LEDs (without a separate light guide) may be embedded in the gel. Similarly, electrical connection to provide power to the micro-LEDs may be made at a surface of the main body 16.
The UVB light emitter 36 may be any suitable source of UVB light. In one embodiment, the UVB light has a spectrum of 310 nm+/−5 nm for the purpose of stimulating vitamin D through skin exposure. The UVB light spectrum may alternatively be 310 nm+/−10 nm or 310 nm+/−20 nm, etc. The spectrum may be chosen as representing an optimum ratio of vitamin D therapeutic benefit vs erythema risk.
The red light emitter 38 may be any suitable source of red light. In one embodiment, the UVB light has a spectrum of 670 nm+/−5 nm for the purpose of stimulating melatonin production through skin exposure. The red light spectrum may alternatively be 660 nm+/−10 nm or 660 nm+/−20 nm, etc.
The power source 14 may be any suitable source of electrical power. For example, the power source 14 may be a battery mechanically supported by the main body 16. The power source 14 may be releasably attached to a clip attached to the main body 16. Alternatively or additionally, the power source 14 may be stored in a pocket of the main body 16.
The processor circuitry 44 may modulate the amount of phototherapeutic light 18 delivered to the skin via the light source 16. For example, the processor circuitry 44 may control at least one of a duration, pattern, wavelength, or intensity of phototherapeutic light 18 emitted by the light source 16. The processor circuitry 44 may modulate the amount of phototherapeutic light 18 to provide a therapeutically effective dose to treat vitamin D deficiency.
The processor circuitry 44 may have various implementations. For example, the processor circuitry 44 may include any suitable device, such as a processor (e.g., CPU), programmable circuit, integrated circuit, memory and I/O circuits, an application specific integrated circuit, microcontroller, complex programmable logic device, other programmable circuits, or the like. The processor circuitry 44 may also include a non-transitory computer readable medium, such as random-access memory (RAM), a read-only memory (ROM), an erasable programmable read-only memory (EPROM or Flash memory), or any other suitable medium.
In one embodiment, the phototherapy device may include a sensor configured to sense biometric data of the skin. The processor circuitry 44 may receive an output of the sensor and control the properties of the phototherapeutic light 18 emitted by the light source 16 based on the output of the sensor. For example, the biometric sensor may be a temperature sensor for measuring a temperature of the skin. In this example, the processor circuitry 44 may reduce an output power of the light source 16 when the temperature exceeds a temperature threshold. Alternatively or additionally, the processor circuitry 44 may increase the output power of the light source 16 when the temperature is below the temperature threshold.
All ranges and ratio limits disclosed in the specification and claims may be combined in any manner. Unless specifically stated otherwise, references to “a,” “an,” and/or “the” may include one or more than one, and that reference to an item in the singular may also include the item in the plural.
Although the invention has been shown and described with respect to a certain embodiment or embodiments, equivalent alterations and modifications will occur to others skilled in the art upon the reading and understanding of this specification and the annexed drawings. In particular regard to the various functions performed by the above described elements (components, assemblies, devices, compositions, etc.), the terms (including a reference to a “means”) used to describe such elements are intended to correspond, unless otherwise indicated, to any element which performs the specified function of the described element (i.e., that is functionally equivalent), even though not structurally equivalent to the disclosed structure which performs the function in the herein illustrated exemplary embodiment or embodiments of the invention. In addition, while a particular feature of the invention may have been described above with respect to only one or more of several illustrated embodiments, such feature may be combined with one or more other features of the other embodiments, as may be desired and advantageous for any given or particular application.
This application claims the benefit of U.S. 63/239,636 filed on Sep. 1, 2022. Which is herein incorporated by reference in its entirety.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US2022/075626 | 8/30/2022 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 63239636 | Sep 2021 | US |
